Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.
Journal: Clinical sarcoma research
Published: May 16, 2018
A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma.
Journal: International journal of cancer
Published: September 14, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026